Grown Rogue International (GRUSF) Beginning Cash Balance (2009 - 2025)
Grown Rogue International's (GRUSF) quarterly Beginning Cash Balance came in at $3.3 million in Q1 2025, down 35.38% year-on-year from $5.0 million in Q1 2024, and down 35.38% quarter-over-quarter from $5.0 million in Q1 2024.
Grown Rogue International (GRUSF) Beginning Cash Balance (2009 - 2025) Analysis & Trends
Grown Rogue International's Beginning Cash Balance history runs 15 years deep, the most recent figure standing at $3.3 million for Q1 2025.
- On a quarterly basis, Beginning Cash Balance fell 35.38% year-over-year to $3.3 million in Q1 2025; TTM through Mar 2025 was $3.3 million, a 77.65% decrease from a year earlier, with the FY2024 full-year figure at $5.0 million, down 23.62% from the prior year.
- Beginning Cash Balance slipped to $3.3 million in Q1 2025 per GRUSF's latest filing, from $5.0 million in the prior quarter.
- Across five years, Beginning Cash Balance topped out at $5.0 million in Q1 2024 and bottomed at $880177.0 in Q1 2022.
- The 4-year median for Beginning Cash Balance is $3.3 million (2025), against an average of $2.8 million.
- Across the five-year window, Beginning Cash Balance jumped 33.29% in 2023 and plunged 35.38% in 2025, its largest moves.
- Year by year, Beginning Cash Balance stood at $880177.0 in 2022, then soared by 192.26% to $2.6 million in 2023, then soared by 96.3% to $5.0 million in 2024, then tumbled by 35.38% to $3.3 million in 2025.
- Per Business Quant, the three latest GRUSF Beginning Cash Balance figures stand at $3.3 million (Q1 2025), $5.0 million (Q1 2024), and $2.6 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.26 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Mar 31, 2024 | 5.05 Mn |
| Mar 31, 2024 | 5.05 Mn |
| Oct 31, 2023 | 2.57 Mn |
| Oct 31, 2023 | 2.57 Mn |
| Jul 31, 2023 | 3.49 Mn |
| Jul 31, 2023 | 3.49 Mn |
| Apr 30, 2023 | 3.49 Mn |
| Apr 30, 2023 | 3.49 Mn |
| Jan 31, 2023 | 1.17 Mn |
| Jan 31, 2023 | 1.17 Mn |
| Jan 31, 2022 | 880,177.01 |
| Jan 31, 2022 | 880,177.01 |
| Jan 31, 2020 | 74,926.00 |
| Jan 31, 2020 | 74,926.00 |
| Jan 31, 2019 | 826,643.00 |
| Jan 31, 2019 | 826,643.00 |
| Jan 31, 2018 | 453,199.00 |
| Jan 31, 2018 | 453,199.00 |